Infinity Equity
VC Fund
Wan Chai, Hong Kong
Infinity Equity is a VC fund in Wan Chai focused on Medical and Health Care. Infinity Equity provides a platform for fund management.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Infinity Equity invests in
Stages Infinity Equity invests in
Countries Infinity Equity invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anna Wang
|
|||
Avishai Silvershatz
|
|||
Eric Yang
|
|||
Jackie Shen
|
|||
Michael Ding
|
|||
| See all 11 contacts → | |||
Investment Focus
Industry
- Medical 8 (25%)
- Health Care 7 (22%)
- Manufacturing 6 (19%)
- Software 5 (16%)
- Information Technology 4 (13%)
Stage
- Seed 6 (19%)
- Series B 6 (19%)
- Series C 5 (16%)
- Funding Round 5 (16%)
- Series A 4 (13%)
Country
- China 22 (69%)
- Israel 5 (16%)
- United States 3 (9%)
- The Netherlands 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anna Wang
Accounting Manager
|
Accounting Manager | Total investments: 0 | Find email | |
|
Avishai Silvershatz
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
|
Eric Yang
Senior Associate
|
Senior Associate | Total investments: 0 | Find email | |
|
Jackie Shen
Director
|
Director | Total investments: 0 | Find email | |
|
Michael Ding
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
MoleculeMind
|
MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform. | $86M / Series A / Jun 17, 2026 | |
Falcon Technology
|
Falcon Technology focuses on DSA processor design innovation, developing a dedicated computing technology ecosystem based on the RISC-V architecture to deliver high-performance, energy-efficient processing solutions for next-generation intelligent computing applications. | $14.7M / Angel / May 20, 2026 | |
Yaozheng Quantum Technology
|
UnitQC is a China‑based quantum technology company focused on trapped‑ion quantum computing systems and related products. | Seed / Mar 29, 2026 | |
|
Siotop Technology
|
Siotop Technology focuses on the research and development, as well as the sales, of underwater intelligent equipment products. | Series B / Dec 30, 2025 | |
|
Rongfa Technology
|
Rongfa Technology is a technology-based enterprise integrating the production, R&D, and sales of sensor products. | Series A / Dec 17, 2025 | |
Durofi
|
Durofi is an innovative medical device company providing integrated solutions for precise cranial localization and treatment of hypertensive intracerebral hemorrhage (minimally invasive surgery. | Series A / Nov 19, 2025 | |
OYMotion Technologies
|
OYMotion develops bio-metric sensors, machine-learning based algorithm for processing bionic signals and gesture control based on EMG. | $13.9M / Series B / May 13, 2025 | |
OMGene.AI
|
We build behavioral AI models that predict how people and institutions will act.Our technology enables organizations to make better decisions by predicting human behavior at scale. Our Large Behavioral Models transform your existing data into actionable insights, helping leaders anticipate actions, optimize teams, and navigate uncertainty. Wemanaged to do this by being the first company that successfully trained AI models on a combination of proprietary genomic, psychological and behavioral data. OMGene works with partners across defense, capital markets, healthcare, and enterprise to deliver behavioral intelligence where it matters most. | $5M / Venture - Series Unknown / May 01, 2025 | |
HighlightLL Pharma
|
HighlightLL Pharma is a pharmaceutical company. | $20.5M / Series C / Jan 03, 2025 | |
Curegene
|
Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms. | Series B / Oct 31, 2024 | |
| See all 32 investments → | |||
Co-Investors
Infinity Group
4 deals together
Addor Capital
2 deals together
CDH Investments
2 deals together
Co-Stone Venture Capital
2 deals together
Elron Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Infinity Equity invest in?
Infinity Equity invests primarily in Medical, Health Care and Manufacturing startups, most often at Seed and Series B stage. Most of the 32 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Infinity Equity?
Public channels for Infinity Equity include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Infinity Equity?
The team at Infinity Equity includes Anna Wang (Accounting Manager), Avishai Silvershatz (Managing Partner) and Eric Yang (Senior Associate), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
